Comparison between Invicta Diagnostic IPO and R. P. Multimetals IPO.
Invicta Diagnostic IPO is a SME Bookbuilding IPO proposed to list at NSE SME while R. P. Multimetals IPO is a SME Bookbuilding proposed to list at BSE SME.
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Socradamus Capital Pvt.Ltd. | Fintellectual Corporate Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Invicta Diagnostic IPO is up to ₹0.00 Cr whereas the issue size of the R. P. Multimetals IPO is up to ₹0.00 Cr. The final issue price of Invicta Diagnostic IPO is and of R. P. Multimetals IPO is .
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 33,08,800 shares | 47,94,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 33,08,800 shares | 47,94,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Invicta Diagnostic IPO opens on , while R. P. Multimetals IPO opens on . The closing date of Invicta Diagnostic IPO and R. P. Multimetals IPO is , and , respectively.
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Invicta Diagnostic IPO P/E ratio is , as compared to R. P. Multimetals IPO P/E ratio of .
| Invicta Diagnostic IPO | R. P. Multimetals IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Invicta Diagnostic Limited Financial Information (Restated Consolidated)Invicta Diagnostic Limited's revenue increased by 90% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2025 and March 31, 2024.
| R. P. Multimetals Ltd. Financial Information (Restated)R. P. Multimetals Ltd.'s revenue decreased by 18% and profit after tax (PAT) rose by 36% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.89 | 86.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 63.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.28% | 21.83% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 42.00% | 13.90% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.26 | 1.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.25% | 21.83% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Invicta Diagnostic IPO Retail Individual Investors (RII) are offered 0 shares while in R. P. Multimetals IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Invicta Diagnostic IPO and 0 shares in R. P. Multimetals IPO.
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| Anchor Investor Reserveration | 0 shares | 0 shares |
| Market Maker Reserveration | 0 shares | 2,53,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Invicta Diagnostic IPO subscribed in total, whereas R. P. Multimetals IPO subscribed .
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
